Sleuths have flagged 30 papers co-authored by Martin Gleave, a professor at the University of British Columbia in Canada and co-founder of the Vancouver Prostate Centre. The issues include similarities within individual papers and across multiple publications, with some comments suggesting the alleged reuse of tumor specimens.
This month, the British Journal of Cancer, a Springer Nature publication, published an expression of concern for the 2012 paper "Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model". The paper, a collaboration between Gleave and researchers from Kobe University in Japan, is one of the 30 flagged on PubPeer. Four more of the 30 papers are published in other Springer Nature journals. For the first five papers listed above, authors attributed the errors to students who "inadvertently inserted incorrect images into the figures".
Another 14 of Gleave’s papers flagged on PubPeer were published in American Association for Cancer Research (AACR) journals, with six of them in Molecular Cancer Therapeutics. In an email, Christine Battle, publisher and vice president of scientific publications at AACR, wrote they would be examining the articles and will correct or retract if required.
